Matthieu Jabaudon

Matthieu Jabaudon

Department of Perioperative Medicine, CHU Clermont-Ferrand

Affiliated withCHU Clermont-FerrandUniversité Clermont AuvergneVanderbilt University Medical Center

Research Area

Biography

Matthieu Jabaudon, MD PhD

Associate Professor of Medicine

Department of Perioperative Medicine, CHU Clermont-Ferrand

Team « Translational Approach to epithelial injury and repair”, GReD, Universite Clermont Auvergne, CNRS, INSERM

58 rue Montalembert, 63000Clermont-Ferrand, France

Email: mjabaudon@chu.clermontferrand.fr

Education

MD in Anesthesiology, Critical Care and Perioperative Medicine - Université Clermont Auvergne

PhD in Biological Sciences - Université Clermont Auvergne, GReD, CNRS, INSERM

Postgraduate Training

Visiting Associate Professor of Medicine, Vanderbilt University Medical Center (2019-2020)

Clinical Interest

Dr. Jabaudon cares for critically ill patients in the CHU Clermont-Ferrand Unit where he is passionate about providing outstanding patient care and training the next generation of anesthesiology and critical care physicians. He has a particular interest in acute respiratory distress syndrome and mechanical ventilation.

Research Keywords

Translational research in acute lung injury and repair.

Research Description

Our Hospital research team and University lab do basic, translational and clinical research on the role of the alveolar epithelium in the pathogenesis and resolution of acute lung injury and the acute respiratory distress syndrome (ARDS). Current projects include studies of the effects of inhaled anesthetics (sevoflurane, isoflurane) in acute lung injury and repair, investigation of the role of the receptor for advanced glycation end-products (RAGE) pathway and of the alveolar epithelium in the pathogenesis and resolution of acute lung injury, and translational studies of biomarkers for diagnosis and prognosis in acute lung injury

Publications

https://pubmed.ncbi.nlm.nih.gov/?term=jabaudon+m&sort=date

JoVE Journal Publications

ArticleTotal : 2
Year
<em>In Vitro</em> Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
Publication title
2018
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Publication title

Cited by 2

2020

Other Publications

Article
Year
Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients.

Critical care medicine| PubMed ID: 21220996

2011
2013
2013
2015
2015
2015
Epidural analgesia in the intensive care unit: An observational series of 121 patients.

Anaesthesia, critical care & pain medicine| PubMed ID: 26004880

2015
2015
2016
2016
Sevoflurane for Sedation in Acute Respiratory Distress Syndrome. A Randomized Controlled Pilot Study.

American journal of respiratory and critical care medicine| PubMed ID: 27611637

2017
2017
RAGE inhibition reduces acute lung injury in mice.

Scientific reports| PubMed ID: 28775380

2017
Recruitment maneuvers in acute respiratory distress syndrome.

Annals of translational medicine| PubMed ID: 28828365

2017
Recent directions in personalised acute respiratory distress syndrome medicine.

Anaesthesia, critical care & pain medicine| PubMed ID: 28935455

2018
2018
2018
2018
2018
2018
The authors reply.

Critical care medicine| PubMed ID: 29912120

2018
2018
2018
2018
2019
ARDS in patients with chest trauma: Better safe than sorry.

Anaesthesia, critical care & pain medicine| PubMed ID: 31076142

2019
2019
2019
2019
Eyes wide open on bronchial aeration in acute respiratory distress syndrome.

Anaesthesia, critical care & pain medicine| PubMed ID: 32145431

2020
2020
2020
2020
2020
2020